SUCCINYLCHOLINE CHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for succinylcholine chloride and what is the scope of freedom to operate?
Succinylcholine chloride
is the generic ingredient in five branded drugs marketed by Sandoz, Hospira, Accord Hlthcare, Adaptis, Amneal, Amphastar Pharms Inc, Amring Pharms, Aspiro, Baxter Hlthcare Corp, Be Pharms, Breckenridge, Deva Holding As, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Intl Medication, Mankind Pharma, Meitheal, Micro Labs, Nexus, Organon Usa Inc, Sagent Pharms Inc, Somerset Theraps Llc, Umedica, Zydus Pharms, Apothecon, and Steriscience, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for succinylcholine chloride. Twenty-nine suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for SUCCINYLCHOLINE CHLORIDE
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 29 |
NDAs: | 31 |
Drug Master File Entries: | 5 |
Finished Product Suppliers / Packagers: | 29 |
Raw Ingredient (Bulk) Api Vendors: | 39 |
Clinical Trials: | 2 |
Patent Applications: | 2,291 |
Drug Prices: | Drug price trends for SUCCINYLCHOLINE CHLORIDE |
What excipients (inactive ingredients) are in SUCCINYLCHOLINE CHLORIDE? | SUCCINYLCHOLINE CHLORIDE excipients list |
DailyMed Link: | SUCCINYLCHOLINE CHLORIDE at DailyMed |
Recent Clinical Trials for SUCCINYLCHOLINE CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rutgers, The State University of New Jersey | N/A |
Avera Pharmaceuticals | Phase 1/Phase 2 |
Generic filers with tentative approvals for SUCCINYLCHOLINE CHLORIDE
Applicant | Application No. | Strength | Dosage Form |
⤷ Sign Up | ⤷ Sign Up | 100MG/5ML (20MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for SUCCINYLCHOLINE CHLORIDE
Drug Class | Depolarizing Neuromuscular Blocker |
Physiological Effect | Neuromuscular Depolarizing Blockade |
Medical Subject Heading (MeSH) Categories for SUCCINYLCHOLINE CHLORIDE
US Patents and Regulatory Information for SUCCINYLCHOLINE CHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breckenridge | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 212638-001 | Oct 9, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | QUELICIN PRESERVATIVE FREE | succinylcholine chloride | INJECTABLE;INJECTION | 008845-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Meitheal | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 214514-001 | Oct 19, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sandoz | ANECTINE | succinylcholine chloride | INJECTABLE;INJECTION | 008453-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Intl Medication | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 085400-001 | Feb 4, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.